Zurcher Kantonalbank (Zurich Cantonalbank) Editas Medicine, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$41.5 Billion
Q3 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 360 shares of EDIT stock, worth $936. This represents 0.0% of its overall portfolio holdings.

Number of Shares

360

Previous 360 -0.0%

Holding current value

$936

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$0.98 - $2.35 $6,068 - $14,551	-6,192 Reduced 94.51%	360 $0
Q1 2025 May 07, 2025	BUY	$1.14 - $3.2 $91 - $256	80 Added 1.24%	6,552 $7,000
Q4 2024 Feb 07, 2025	SELL	$1.2 - $3.76 $20,373 - $63,837	-16,978 Reduced 72.4%	6,472 $8,000
Q3 2024 Nov 07, 2024	SELL	$3.39 - $5.96 $2,701 - $4,750	-797 Reduced 3.29%	23,450 $79,000
Q2 2024 Jul 29, 2024	SELL	$4.67 - $7.28 $354 - $553	-76 Reduced 0.31%	24,247 $113,000
Q1 2024 Apr 25, 2024	SELL	$7.03 - $11.07 $36,092 - $56,833	-5,134 Reduced 17.43%	24,323 $180,000
Q4 2023 Jan 30, 2024	SELL	$6.25 - $11.11 $1,093 - $1,944	-175 Reduced 0.59%	29,457 $298,000
Q3 2023 Oct 25, 2023	BUY	$6.92 - $9.31 $52,412 - $70,513	7,574 Added 34.34%	29,632 $231,000
Q2 2023 Aug 07, 2023	BUY	$6.36 - $11.47 $8,000 - $14,429	1,258 Added 6.05%	22,058 $181,000
Q1 2023 May 08, 2023	BUY	$7.03 - $11.53 $18,102 - $29,689	2,575 Added 14.13%	20,800 $150,000
Q4 2022 Feb 01, 2023	BUY	$8.32 - $13.21 $216 - $343	26 Added 0.14%	18,225 $161,000
Q3 2022 Nov 09, 2022	SELL	$12.16 - $19.42 $9,375 - $14,972	-771 Reduced 4.06%	18,199 $223,000
Q2 2022 Aug 09, 2022	SELL	$9.99 - $21.35 $6,063 - $12,959	-607 Reduced 3.1%	18,970 $224,000
Q1 2022 Apr 21, 2022	BUY	$14.08 - $27.63 $25,780 - $50,590	1,831 Added 10.32%	19,577 $372,000
Q4 2021 Feb 01, 2022	BUY	$26.55 - $40.57 $75,428 - $115,259	2,841 Added 19.06%	17,746 $471,000
Q3 2021 Nov 15, 2021	BUY	$39.27 - $72.94 $27,646 - $51,349	704 Added 4.96%	14,905 $612,000
Q2 2021 Jul 30, 2021	BUY	$31.29 - $56.64 $11,295 - $20,447	361 Added 2.61%	14,201 $804,000
Q1 2021 May 03, 2021	BUY	$39.71 - $90.58 $163,287 - $372,464	4,112 Added 42.27%	13,840 $581,000
Q4 2020 Jan 28, 2021	BUY	$27.07 - $84.35 $93,499 - $291,344	3,454 Added 55.05%	9,728 $682,000
Q2 2020 Jul 28, 2020	BUY	$18.5 - $34.34 $20,831 - $38,666	1,126 Added 21.87%	6,274 $186,000
Q1 2020 May 06, 2020	BUY	$14.88 - $32.78 $13,198 - $29,075	887 Added 20.82%	5,148 $102,000
Q3 2019 Oct 18, 2019	BUY	$22.49 - $26.81 $13,898 - $16,568	618 Added 16.96%	4,261 $97,000
Q2 2019 Jul 30, 2019	BUY	$20.48 - $27.76 $37,007 - $50,162	1,807 Added 98.42%	3,643 $90,000
Q1 2019 Apr 29, 2019	SELL	$19.43 - $26.41 $14,261 - $19,384	-734 Reduced 28.56%	1,836 $45,000
Q4 2017 Jan 31, 2018	BUY	$21.89 - $31.34 $19,153 - $27,422	875 Added 51.62%	2,570 $79,000
Q3 2017 Nov 08, 2017	BUY	$15.81 - $24.01 $26,797 - $40,696	1,695	1,695 $41,000

Others Institutions Holding EDIT

# of Institutions

225

Shares Held

46.2M

Call Options Held

841K

Put Options Held

304K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $179M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Editas Medicine, Inc. Transaction History